NCT01332344View on ClinicalTrials.gov

Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids

CompletedOBSERVATIONAL
Enrollment

5,180

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Asthma
Interventions
DRUG

Fluticasone propionate/salmeterol combination

Asthma subjects newly prescribed fluticasone propionate/salmeterol combination

DRUG

Inhaled corticosteroids

asthma subjects newly prescribed inhaled corticosteroids in clinical practice

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01332344 - Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids | Biotech Hunter | Biotech Hunter